We performed a randomized controlled trial with the glucagon‐like peptide‐1 ( GLP ‐1) receptor agonist exenatide as add‐on to standard peri‐operative insulin therapy in patients undergoing elective cardiac surgery. The aims of the study were to intensify peri‐operative glucose control while minim…